{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:30:23Z","timestamp":1789965023621,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30801179"],"award-info":[{"award-number":["30801179"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Social development projects of Shanxi Province","award":["2012K-02-01"],"award-info":[{"award-number":["2012K-02-01"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.brainres.2014.08.030","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T09:23:50Z","timestamp":1408613030000},"page":"9-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Role of the Akt\/GSK-3\u03b2\/CRMP-2 pathway in axon degeneration of dopaminergic neurons resulting from MPP+ toxicity"],"prefix":"10.1016","volume":"1602","author":[{"given":"Wei","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haikang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2014.08.030_bib42","doi-asserted-by":"crossref","first-page":"31375","DOI":"10.1074\/jbc.M109.009951","article-title":"An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels","volume":"284","author":"Brittain","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2014.08.030_bib15","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1016\/j.febslet.2005.07.058","article-title":"The parkinsonism producing neurotoxin MPP+ affects microtubule dynamics by acting as a destabilising factor","volume":"579","author":"Cappelletti","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.brainres.2014.08.030_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1471-4159.2010.06924.x","article-title":"Microtubule dysfunction precedes transport impairment and mitochondria damage in MPP+-induced neurodegeneration","volume":"115","author":"Cartelli","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2014.08.030_bib27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/(SICI)1097-4547(20000101)59:1<126::AID-JNR15>3.0.CO;2-L","article-title":"Acute ultrastructural effects of MPTP on the nigrostriatal pathway of the C57BL\/6 adult mouse: evidence of compensatory plasticity in nigrostriatal neurons","volume":"59","author":"Cochiolo","year":"2000","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.brainres.2014.08.030_bib17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nrn1788","article-title":"Axon degeneration mechanisms: commonality amid diversity","volume":"6","author":"Coleman","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2014.08.030_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tins.2007.02.004","article-title":"Neuronal death: where does the end begin","volume":"30","author":"Conforti","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainres.2014.08.030_bib30","first-page":"1437","volume":"122","author":"Damier","year":"1999","journal-title":"The substantia Nigra of the human brain II. Patterns of loss of dopamine \u2013 containing neurons in Parkinson\u05f3s disease"},{"key":"10.1016\/j.brainres.2014.08.030_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.brainres.2008.03.060","article-title":"Dystrophic serotonergic axons in neurodegenerative diseases","volume":"1217","author":"Efrain","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2014.08.030_bib32","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson\u05f3s disease: Substantia Nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2014.08.030_bib19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/1073858406293853","article-title":"Microtubule: a common target for parkin and Parkinson\u05f3s disease toxins","volume":"12","author":"Feng","year":"2006","journal-title":"Neuroscientist"},{"key":"10.1016\/j.brainres.2014.08.030_bib11","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1523\/JNEUROSCI.20-04-01333.2000","article-title":"Evidence thatWallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases","volume":"20","author":"Finn","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2014.08.030_bib31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000107704","article-title":"Axonal degeneration in motor neuron disease","volume":"4","author":"Fischer","year":"2007","journal-title":"Neurodegener Dis."},{"key":"10.1016\/j.brainres.2014.08.030_bib5","doi-asserted-by":"crossref","first-page":"43628","DOI":"10.1074\/jbc.M308947200","article-title":"Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons","volume":"278","author":"Goldberg","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2014.08.030_bib29","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1523\/JNEUROSCI.20-09-03182.2000","article-title":"Glial cell line \u2013 derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons","volume":"20","author":"Granholm","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2014.08.030_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.expneurol.2006.05.017","article-title":"Wld(S) mice are protected against the Parkinsonian mimetic MPTP","volume":"202","author":"Hasbani","year":"2006","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.brainres.2014.08.030_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0306-4522(91)90180-V","article-title":"Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study","volume":"40","author":"Herkenham","year":"1991","journal-title":"Neurosci."},{"key":"10.1016\/j.brainres.2014.08.030_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/exnr.1994.1205","article-title":"Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra","volume":"130","author":"Ichitani","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2014.08.030_bib40","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/90476","article-title":"CRMP-2 induces axons in cultured hippocampal neurons","volume":"4","author":"Inagaki","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2014.08.030_bib38","first-page":"123","article-title":"Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3b and its upstream regulators","volume":"120","author":"Jiang","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.brainres.2014.08.030_bib20","first-page":"295","article-title":"Is the Initial Insult in Parkinson\u05f3s Disease and Dementia with Lewy Bodies a Neuritic Dystrophy?","volume":"991","author":"John","year":"2003","journal-title":"Parkinson\u05f3s Dis.: The Life Cycle of the Dopamine Neuron \u2013 Ann NY Acad Sci"},{"key":"10.1016\/j.brainres.2014.08.030_bib43","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.neuroscience.2006.08.070","article-title":"Neurotransmitter receptors in the life and death of oligodendrocytes","volume":"145","author":"Karadottir","year":"2007","journal-title":"Neurosci"},{"key":"10.1016\/j.brainres.2014.08.030_bib3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ncpneuro0491","article-title":"Why hasn\u2019t neuroprotection worked in Parkinson\u2019s disease?","volume":"l3","author":"Kieburtz","year":"2007","journal-title":"Nat. Clin. Pract. Neuro."},{"key":"10.1016\/j.brainres.2014.08.030_bib34","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","article-title":"Uneven pattern of dopamine loss in thestriatum of patients with idiopathic Parkinson\u05f3s disease. Pathophysiologic and clinical implications","volume":"318","author":"Kish","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2014.08.030_bib1","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson\u05f3s disease. First of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2014.08.030_bib6","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1111\/j.1460-9568.2006.05210.x","article-title":"Impairment of microtubule-dependent trafficking by overexpression of alpha-synuclein","volume":"24","author":"Lee","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2014.08.030_bib2","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson\u05f3s disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2014.08.030_bib22","doi-asserted-by":"crossref","first-page":"15970","DOI":"10.1074\/jbc.M510934200","article-title":"Myelin-associated glycoprotein inhibits microtubule assembly by a Rho-kinase-dependent mechanism","volume":"281","author":"Mimura","year":"2006","journal-title":"T. J. Biol. Chem."},{"key":"10.1016\/j.brainres.2014.08.030_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","article-title":"Molecular pathophysiology of Parkinson\u05f3s disease","volume":"28","author":"Moore","year":"2005","journal-title":"Annu. Rev. Neurosci"},{"key":"10.1016\/j.brainres.2014.08.030_bib37","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1073\/pnas.0611231104","article-title":"Opalach .1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C","volume":"104","author":"Morfini","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.brainres.2014.08.030_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuroscience.2006.02.007","article-title":"Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1, 2, 3, 6-Tetrahydropyridine\/probenecid model of Parkinson\u05f3s disease","author":"Novikova","year":"2006","journal-title":"Neurosci 140"},{"key":"10.1016\/j.brainres.2014.08.030_bib33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/jnnp.54.1.30","article-title":"The absolute number of nerve cells in substantia nigra in normal subjects and in patientswith Parkinson\u2019s disease estimated with an unbiased stereological method","volume":"54","author":"Pakkenberg","year":"1991","journal-title":"J. Neurol. Neurosurg. Psych."},{"key":"10.1016\/j.brainres.2014.08.030_bib12","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.1068613","article-title":"Axonal self-destruction and neurodegeneration","volume":"296","author":"Raff","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.brainres.2014.08.030_bib18","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1523\/JNEUROSCI.23-08-03316.2003","article-title":"Parkin binds to alpha\/beta tubulin and increases their ubiquitination and degradation","volume":"23","author":"Ren","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2014.08.030_bib7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.cub.2004.01.053","article-title":"Wlds-mediated protection of dopaminergic fibers in an animal model of Parkinson disease","volume":"14","author":"Sajadi","year":"2004","journal-title":"Curr. Biol.: CB"},{"key":"10.1016\/j.brainres.2014.08.030_bib13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.pneurobio.2007.07.007","article-title":"Mechanisms of axon degeneration: From development to disease","volume":"83","author":"Saxena","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainres.2014.08.030_bib24","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1046\/j.1471-4159.1999.0730961.x","article-title":"Semaphorins as mediators of neuronal apoptosis","volume":"73","author":"Shirvan","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2014.08.030_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.10593","article-title":"False resurrections: Distinguishing regenerated from spared axons in the injured central nervous system","volume":"459","author":"Steward","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainres.2014.08.030_bib10","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1126\/science.1105681","article-title":"Axonopathy and transport deficits early in the pathogenesis of Alzheimer\u05f3s disease","volume":"307","author":"Stokin","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.brainres.2014.08.030_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2443.2005.00827.x","article-title":"Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer\u05f3s disease","volume":"10","author":"Uchida","year":"2005","journal-title":"Genes to Cells: Devoted to Mol. Cell. Mechan."},{"key":"10.1016\/j.brainres.2014.08.030_bib25","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/ncb2373","article-title":"ZNRF1 promotes Wallerian degeneration by degrading AKT to induce GSK3\u03b2-dependent CRMP2 phosphorylation","volume":"13","author":"Wakatsuki","year":"2011","journal-title":"Nat. Cell. Biol"},{"key":"10.1016\/j.brainres.2014.08.030_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuroscience.2012.04.052","article-title":"Involvement of the AKT\/GSK-3\u03b2\/CRMP-2 pathway in axonal injury after hypoxic-ischemic brain damage in neonatal rat","volume":"216","author":"Xiong","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2014.08.030_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cell.2004.11.012","article-title":"GSK-3b regulates phosphorylation of CRMP-2 and neuronal polarity","volume":"120","author":"Yoshimura","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.brainres.2014.08.030_bib41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbrc.2005.11.147","article-title":"Ras regulates neuronal polarity via the PI3-kinase\/Akt\/GSK-3beta\/CRMP-2 pathway","volume":"340","author":"Yoshimura","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2014.08.030_bib44","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1096\/fj.04-1586fje","article-title":"3-hydroxymorphinanis neurotrophic to dopaminergic neurons and is also neuroprotective againstLPS-induced neurotoxicity","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899314011056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899314011056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T04:56:19Z","timestamp":1565758579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899314011056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":44,"alternative-id":["S0006899314011056"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2014.08.030","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of the Akt\/GSK-3\u03b2\/CRMP-2 pathway in axon degeneration of dopaminergic neurons resulting from MPP+ toxicity","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2014.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}